NOC Northrop Grumman Earnings: Q1 2026 Results Recap

Northrop Grumman Corporation NOC reported earnings on April 21, 2026, with limited financial data available for this quarter. The aerospace and defense giant operates across four major segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. With a market cap of $86.8 billion and 97,000 employees, NOC serves critical defense and space markets. The stock declined sharply following the announcement, falling 6.98% to $611.14. Meyka AI rates NOC with a grade of B+, reflecting solid fundamentals despite recent market headwinds.

Q1 2026 Earnings Results and Market Reaction

Northrop Grumman’s Q1 2026 earnings announcement triggered a significant market selloff. The stock dropped $45.84 per share, or 6.98%, closing at $611.14 on April 21, 2026. Trading volume surged to 1.45 million shares, 70% above the 30-day average of 850,000 shares, indicating strong investor reaction.

Stock Price Movement

The decline represents a notable pullback from recent highs. The stock traded between $610.40 and $652.99 during the day, showing volatility around the earnings release. Year-to-date, NOC remains up 15.24%, though the recent weakness has trimmed gains from the 52-week high of $774.00.

Technical Indicators Signal Weakness

Technical analysis shows oversold conditions following the selloff. The Relative Strength Index (RSI) fell to 32.65, indicating oversold territory. The Commodity Channel Index (CCI) dropped to negative 158.54, suggesting extreme pessimism. Williams %R reached negative 98.85, the most bearish reading possible, reflecting capitulation selling.

Historical Earnings Performance and Trends

Northrop Grumman has demonstrated consistent earnings delivery over recent quarters. The company beat EPS estimates in three of the last four reported quarters, showing operational strength despite market challenges.

Recent Quarter Comparisons

In Q4 2025 (ended January 30, 2026), NOC reported EPS of $7.23 versus an estimate of $6.98, beating by $0.25 or 3.6%. Revenue came in at $11.71 billion against an estimate of $9.75 billion. The Q3 2025 quarter showed EPS of $7.67 versus $6.44 estimated, a beat of $1.23 or 19.1%. These strong performances demonstrate management’s ability to execute.

Earnings Consistency

The company’s EPS has ranged from $6.06 to $7.67 over the past six quarters. This consistency reflects stable defense spending and strong contract execution. Revenue estimates have averaged around $10.5 billion quarterly, showing predictable business patterns.

Financial Health and Valuation Metrics

Northrop Grumman maintains solid financial fundamentals despite recent stock weakness. The company’s valuation metrics reflect its quality as a defense contractor with stable cash flows.

Key Financial Ratios

The current PE ratio stands at 21.0x, reasonable for a defense contractor with consistent earnings. Price-to-sales ratio of 2.22x reflects premium valuation typical for quality aerospace and defense firms. Return on equity of 26.5% demonstrates efficient capital deployment. Free cash flow yield of 3.56% provides attractive income potential for long-term investors.

Balance Sheet Strength

NOC maintains a debt-to-equity ratio of 1.18x, manageable for the industry. Operating cash flow per share reached $33.29, while free cash flow per share totaled $23.14. The company generated $4.62 in annual dividends per share, representing a 0.71% yield. Interest coverage of 6.44x shows comfortable debt servicing ability.

Analyst Consensus and Forward Outlook

Wall Street maintains a constructive stance on Northrop Grumman despite the recent selloff. Analyst consensus reflects confidence in the company’s long-term prospects and defense spending trends.

Analyst Ratings

Nineteen analysts rate NOC as a Buy, while seven maintain Hold ratings. No analysts rate the stock as Sell or Strong Sell, indicating broad confidence. The consensus rating of 3.0 translates to a Buy recommendation. This strong support suggests analysts view the recent decline as a buying opportunity.

Growth Prospects

Free cash flow growth of 26.2% year-over-year demonstrates accelerating cash generation. EPS growth of 2.64% reflects steady earnings expansion. The company’s five-year revenue growth per share of 32.8% shows long-term business expansion. Meyka AI’s B+ grade reflects balanced risk-reward, with strong operational metrics offset by valuation and leverage considerations.

Final Thoughts

Northrop Grumman’s recent 6.98% stock decline presents a buying opportunity for long-term investors. Despite the Q1 2026 earnings-driven selloff, the company demonstrates strong fundamentals including 26.2% year-over-year free cash flow growth, 26.5% return on equity, and solid analyst support with 19 Buy ratings. Technical indicators show oversold conditions. With stable defense contracts, consistent dividend growth, and a supportive defense spending environment, the current weakness offers an attractive entry point for quality-focused investors.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.